Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Internal Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Many Chinese stop taking antihypertensives within a few months

NEW YORK (Reuters Health) – Nearly one out of six patients in China who is prescribed an antihypertensive agent will discontinue treatment within 6 months. Multiple factors affect poor adherence rates, including younger age, male sex, being drug...
NEW YORK (Reuters Health) – In patients with metastatic renal cell carcinoma, first-line treatment with interferon (IFN)-alpha plus sunitinib or bevacizumab has “clinically relevant and statistically significant” survival advantages over...

Reuters Health • The Doctor's Channel Daily Newscast

Intensive therapy markedly reduces complications of type 1 diabetes

NEW YORK (Reuters Health) – The results of a 30-year study indicate that intensive glucose control can substantially reduce the rates of retinopathy, nephropathy, and cardiovascular disease in patients with type 1 diabetes. “The demonstration that...